Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.
FDA inspection history in Taizhou City, China, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Taizhou City, China.
Cited most
Across all Zhejiang Hisoar Chuannan Pharmaceutical Co. observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
The complete Zhejiang Hisoar Chuannan Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Taizhou City, China
One Form 483 · 2019 · 2 observations
Latest: Form 483, Sep 20, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-09-20 | 483 Form 483 | Taizhou City, China | 2 | $99 |
Investigators on these documents
FEI number 3006545436 · most recent document Sep 20, 2019
About Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.
How many FDA Form 483s has Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.; the most recent is dated Sep 20, 2019.
When was Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. is a Form 483 dated Sep 20, 2019, for the site in Taizhou City, China.
What did FDA cite at Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.192 (Production record review), 1 time.